CONFIDENTIALITY
All data reported via this sheet, including the data on the identity of the persons concerned, will be treated confidentially in accordance with the provisions of Belgian and European legislation. This information may also be accessed by other members of the group of companies and relevant licensing partners (some of whom live abroad) as part of the company's global adverse event reporting database. The personal data provided by you will be processed by Qplus consult bv and Laboratoires S.M.B., the holder of the Marketing Authorization (MA), for the purposes of pharmacovigilance as reported to the Commission for the Protection of Privacy. You have the right to access your personal data that we hold about you by contacting our Privacy Officer via email notification to info@qplusconsult.com. Qplus consult bv and Laboratoires S.M.B. comply with the conditions of the Privacy Act .
REMARK
Contact your doctor or pharmacist if in doubt about the symptoms observed and their evolution or to get more information. The report you made via this sheet does not replace the consultation of a doctor. The purpose of reporting an adverse reaction is to contribute to monitoring the safety of medicines and to ensuring that the benefits of medicines outweigh their risks. You can send your questions about reporting an adverse reaction to vigsmb@qplusconsult.com